Novo diabetes site adds new tools to self-manage

Share this article:
Novo Nordisk has unveiled a revamped diabetes care Web site to communicate with patients seeking help in the self-management of the disease.

ChangingDiabetes-us.com features new tools and content developed in response to findings from the Diabetes Attitudes, Wishes and Needs (DAWN) study, a 5,426-patient survey commissioned by Novo Nordisk.

“The DAWN Study has given us valuable insights into how people cope with diabetes at diagnosis and throughout the disease process,” said Susan Harrow Rago, associate director, patient services & professional relations, in a statement.

According to Rago, the site’s new tools will help diabetes patients collaborate more effectively to develop treatment programs tailored to their individual needs.

Content highlights include:
• Guide Me—a feature allowing diabetes patients to customize the site content based on their personal diagnosis.
• Diabetes Care Plan—an interactive tool that helps users track, manage and set goals for their diabetes care.
• My Priorities—a feature to help patients develop personal diabetes care goals and a psychosocial profile.

Users can also sign up to receive regular e-mail communications on diabetes topics from Novo Nordisk and link to divabetic.org, a diabetes outreach site for women.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.